Abhilash Sharma

In-Silico Identification of MurX as a Novel Drug Target in Mycobacterium tuberculosis and Molecular Docking Analysis of Bergenin

Findings support MurX as a viable therapeutic target and Bergenin as a promising candidate for further anti-TB drug development, and lays the foundation for subsequent experimental validation and the design of novel therapeutics targeting resistant strains of Mtb.